Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complex immune correlates of protection in HIV‐1 vaccine efficacy trials
Georgia D. Tomaras, Stanley A. Plotkin
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 245-261
Open Access | Times Cited: 100

Showing 26-50 of 100 citing articles:

The US Military Commitment to Vaccine Development: A Century of Successes and Challenges
Silvia Ratto‐Kim, In-Kyu Yoon, Robert Paris, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 28
Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization
Qi Han, Todd Bradley, Wilton B. Williams, et al.
Cell Reports (2020) Vol. 30, Iss. 5, pp. 1553-1569.e6
Open Access | Times Cited: 23
Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection
Kelly E. Seaton, Rachel L. Spreng, Milite Abraha, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 20
Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model
Godfrey Dzhivhuho, Samantha A. Rehrl, Hlumani Ndlovu, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 7, pp. e1007182-e1007182
Open Access | Times Cited: 26
Virus-Like-Vaccines against HIV
Anne‐Marie Andersson, Melanie Schwerdtfeger, Peter Johannes Holst
Vaccines (2018) Vol. 6, Iss. 1, pp. 10-10
Open Access | Times Cited: 25
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost
Benedikt Asbach, Karen V. Kibler, Josef Köstler, et al.
Journal of Virology (2018) Vol. 93, Iss. 3
Open Access | Times Cited: 25
Rectal Microbiome Composition Correlates with Humoral Immunity to HIV-1 in Vaccinated Rhesus Macaques
Sonny R. Elizaldi, Anil Verma, Korey A. Walter, et al.
mSphere (2019) Vol. 4, Iss. 6
Open Access | Times Cited: 23
Early T follicular helper cell activity accelerates hepatitis C virus-specific B cell expansion
Eduardo Salinas, Maude Boisvert, Amit A. Upadhyay, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 2
Open Access | Times Cited: 19
Strategies for Immunomonitoring after Vaccination and during Infection
Lucille Adam, Pierre Rosenbaum, Olivia Bonduelle, et al.
Vaccines (2021) Vol. 9, Iss. 4, pp. 365-365
Open Access | Times Cited: 18
Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature
Cheng Cheng, Hongying Duan, Kai Xu, et al.
Cell Reports (2020) Vol. 32, Iss. 5, pp. 107981-107981
Open Access | Times Cited: 19
Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses
Per Johan Klasse, John P. Moore
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 11
Molecular epidemiology of a primarily MSM acute HIV‐1 cohort in Bangkok, Thailand and connections within networks of transmission in Asia
David Chang, Eric Sanders‐Buell, Meera Bose, et al.
Journal of the International AIDS Society (2018) Vol. 21, Iss. 11
Open Access | Times Cited: 19
Shigella -Specific Immune Profiles Induced after Parenteral Immunization or Oral Challenge with Either Shigella flexneri 2a or Shigella sonnei
Kristen A. Clarkson, Chad K. Porter, Kawsar R. Talaat, et al.
mSphere (2021) Vol. 6, Iss. 4
Open Access | Times Cited: 15
Does Antigen Glycosylation Impact the HIV-Specific T Cell Immunity?
Àlex Olvera, Samandhy Cedeño, Anuska Llano, et al.
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 14
Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials
Yunda Huang, Shelly Karuna, Lindsay N. Carpp, et al.
Human Vaccines & Immunotherapeutics (2018) Vol. 14, Iss. 9, pp. 2116-2127
Open Access | Times Cited: 18
First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines
Francesco Borriello, Simon D. van Haren, Ofer Levy
mSphere (2018) Vol. 3, Iss. 4
Open Access | Times Cited: 18
V2-Specific Antibodies in HIV-1 Vaccine Research and Natural Infection: Controllers or Surrogate Markers
Ralf Duerr, Miroslaw K. Górny
Vaccines (2019) Vol. 7, Iss. 3, pp. 82-82
Open Access | Times Cited: 16
Immune Correlates of Disease Progression in Linked HIV-1 Infection
Michael Tuen, Jude Bimela, Andrew N. Banin, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 15
Bringing the path toward an HIV-1 vaccine into focus
Cesar J. Lopez Angel, Georgia D. Tomaras
PLoS Pathogens (2020) Vol. 16, Iss. 9, pp. e1008663-e1008663
Open Access | Times Cited: 15
Multiparameter Flow Cytometry Monitoring of T Cell Responses
Holden T. Maecker
Methods in molecular biology (2024), pp. 325-342
Closed Access | Times Cited: 1
Immunoglobulin G1 Allotype Influences Antibody Subclass Distribution in Response to HIV gp140 Vaccination
Sven Kratochvil, Paul F. McKay, Amy W. Chung, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 14
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
Dieter Mielke, Gama Bandawe, Jie Zheng, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 11, pp. e1010046-e1010046
Open Access | Times Cited: 12
Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques
Hongzhao Li, Hai Yan, So‐Yon Lim, et al.
PLoS ONE (2018) Vol. 13, Iss. 8, pp. e0202997-e0202997
Open Access | Times Cited: 14
Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
Jean‐Pierre Routy, Vikram Mehraj
AIDS Research and Therapy (2017) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1
Srivamshi Pittala, Kyle S. Morrison, Margaret E. Ackerman
Current Opinion in HIV and AIDS (2019) Vol. 14, Iss. 4, pp. 253-264
Open Access | Times Cited: 12

Scroll to top